Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06688539 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

E-cigarette Cessation in Adults Who Co-use Cannabis

Study acronym: VapeCAT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jun 1, 2026 to Mar 1, 2027 Completion date: Sep 1, 2026 to Jun 1, 2027 · Site contacts updated at 1 of 3 sitesv7 Show 2 more changesShow less
    • Completion date: Sep 1, 2026 to Jun 1, 2027
    • Site contacts updated at 1 of 3 sites
  2. Primary completion date: Oct 1, 2026 to Jun 1, 2026 Completion date: Dec 1, 2026 to Sep 1, 2026 · Site details revised at 2 of 3 sitesv6 Show 2 more changesShow less
    • Completion date: Dec 1, 2026 to Sep 1, 2026
    • Site details revised at 2 of 3 sites
  3. Primary completion date: Jul 1, 2026 to Oct 1, 2026 Completion date: Oct 1, 2026 to Dec 1, 2026v5 Show 1 more changeShow less
    • Completion date: Oct 1, 2026 to Dec 1, 2026
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 10, 2025 to Feb 19, 2025 · Site details revised at 3 of 3 sitesv4 Show 2 more changesShow less
    • Start date changed from estimate of Feb 10, 2025 to Feb 19, 2025
    • Site details revised at 3 of 3 sites
  5. Start date: Dec 9, 2024 to Feb 10, 2025 Primary completion date: Jun 1, 2026 to Jul 1, 2026 · Completion date: Sep 1, 2026 to Oct 1, 2026v3 Show 2 more changesShow less
    • Primary completion date: Jun 1, 2026 to Jul 1, 2026
    • Completion date: Sep 1, 2026 to Oct 1, 2026
  6. Secondary endpoints: details revised at 1 of 2 entriesv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to better understand tobacco outcomes using a commonly prescribed stop smoking medication (varenicline) and financial incentives for adults who also use cannabis. Varenicline is not FDA approved for e-cigarette cessation, but is FDA approved for cigarette cessation. Investigators are also interested in how cannabis/marijuana and tobacco interact during a tobacco quit attempt. All participants will receive e-cigarette cessation treatment for 12 weeks. To qualify, participants must be between the ages of 18-40 and use both e-cigarettes and cannabis. Participants do not need to be interested in quitting cannabis to qualify. This study is being conducted at three sites: the Medical University of South Carolina in Charleston, SC, Behavioral Health Services in Pickens, SC, and MUSC Lancaster in Lancaster, SC.
Trial Details
NCT Number NCT06688539
Lead Sponsor Medical University of South Carolina
Collaborators: National Cancer Institute (NCI)
Conditions Nicotine Dependence, Tobacco Use Disorder
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov